ribavirin and HIV
ribavirin has been researched along with HIV in 99 studies
Research
Studies (99)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (14.14) | 18.7374 |
| 1990's | 8 (8.08) | 18.2507 |
| 2000's | 35 (35.35) | 29.6817 |
| 2010's | 39 (39.39) | 24.3611 |
| 2020's | 3 (3.03) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Balzarini, J; De Clercq, E; Hermkens, PH; Kruse, CG; Scheeren, HW; Van Maarseveen, JH | 1 |
| Balzarini, J; Calvo-Mateo, A; Camarasa, MJ; De Clercq, E; De las Heras, FG; Diaz-Ortiz, A | 1 |
| Asaftei, S; De Clercq, E | 1 |
| Andrei, G; Balzarini, J; Dračínský, M; Holý, A; Krečmerová, M; Snoeck, R; Tichý, T | 1 |
| Geng, Y; Li, Y; Liu, Y; Qiao, W; Tan, J; Wang, L; Wang, M; Wang, Q; Wang, Z; Yao, X | 1 |
| Baier, A; Cova, L; Hosmane, RS; Zhang, N; Zhang, P | 1 |
| Bellón, JM; Berenguer, J; Carrero, A; Esteban, H; Galindo, MJ; González-García, J; Guardiola, JM; Hernández-Quero, J; Hontañón, V; Jiménez-Sousa, MA; Martínez, E; Navarro, J; Pérez-Latorre, L; Quereda, C; Resino, S; Santos, I; Sanz, J; Téllez, MJ; von Wichmann, MA | 1 |
| Dehghan Manshadi, SA; Kalantari, S; Karimi, J; Malekzadeh, R; Malekzadeh, Z; Mardani, M; Merat, D; Merat, S; Mirminachi, B; Mohraz, M; Nikbin, M; Norouzi, A; Poustchi, H; Rasoolinejad, M; Sali, S; Sedghi, R; Sharifi, AH; Somi, MH; Tabarsi, P; Tayeri, K | 1 |
| Flisiak, R; Groth, M; Grubczak, K; Grzeszczuk, A; Hryniewicz, A; Kretowska-Grunwald, A; Moniuszko, M | 1 |
| Álvarez, B; Benito, JM; Cabello, A; García, M; García-Samaniego, J; Górgolas, M; Madejón, A; Martín-Carbonero, L; Rallón, N | 1 |
| Cairó, M; Carrion, JA; Cifuentes, C; Crespo, M; Cucurull, J; Erice, E; Force, L; Guardiola, JM; Laguno, M; Marco, A; Navarro, J; Roget, M; Vilaró, J; Vilchez, HH | 1 |
| Han, M; Huang, W; Li, X; Wu, X; Yu, F; Zhao, X | 1 |
| Sulkowski, MS | 1 |
| Bani-Sadr, F; Carrieri, P; Dabis, F; Loko, MA; Marchou, B; Morlat, P; Neau, D; Pambrun, E; Salmon, D; Winnock, M | 1 |
| Branch, AD; Chung, RT; Glesby, MJ; Hollabaugh, K; Kang, M; Wyatt, CM | 1 |
| Abdel-Mohsen, M; Deeks, SG; Deng, X; Ghanem, Hel-D; Guatelli, JC; Günthard, HF; Ledergerber, B; Liegler, T; Pillai, SK; Rauch, A; Salama, MS; Wong, JK | 1 |
| Kottilil, S; Lee, YJ; Murphy, A; Shivasabesan, G; Siebenlist, U; Suffredini, AF; Vazquez, E; Wang, H; Young, HA; Zhang, X | 1 |
| Barin, B; Barnes, D; Curry, M; Dove, L; Johl, J; Millis, M; Peters, M; Poordad, F; Reddy, KR; Regenstein, F; Roland, M; Schiano, T; Schiff, E; Shaikh, O; Shetty, K; Stock, P; Terrault, N | 1 |
| Abradelo, M; Agüero, F; Aguilera, V; Antela, A; Barcena, R; Bernal, C; Castells, L; de la Rosa, G; Del Campo, S; Esteban-Mur, JI; Fernandez, JR; González-García, J; Laguno, M; Manzardo, C; Miro, JM; Montero, JL; Olivares, S; Perez, I; Rimola, A; Rodriguez, M; Salcedo, M; Suarez, F; Valdivieso, A; Xiol, X | 1 |
| Bhagani, S; Collado, A; de Los Santos-Gil, I; Delgado, M; Fehr, J; Haberl, A; López-Cortés, LF; Lutz, T; Mandorfer, M; Márquez, M; Mauss, S; Munteanu, DI; Neukam, K; Pineda, JA; Rivero, A; Rivero-Juárez, A; Rockstroh, JK; Scholten, S; Stoeckle, M | 1 |
| Bukowska-Ośko, I; Caraballo Cortés, K; Fic, M; Horban, A; Kaźmierczak, J; Kubisa, N; Laskus, T; Pawełczyk, A; Perlejewski, K; Popiel, M; Płoski, R; Radkowski, M; Rosińska, M; Ząbek, P | 1 |
| Anagnostopoulos, A; Aouri, M; Böni, J; Braun, DL; Decosterd, L; Durisch, N; Eberhard, N; Fehr, J; Ledergerber, B; Metzner, KJ; Müllhaupt, B; Rauch, A; Weber, R | 1 |
| Cooper, C; Dieterich, D; Dvory-Sobol, H; Han, L; McHutchison, JG; Naggie, S; Pang, PS; Saag, M; Stamm, LM; Sulkowski, M; Yang, JC | 1 |
| Aguilera, A; Arias, A; Benítez-Gutiérrez, L; Cuervas-Mons, V; de Mendoza, C; Lledó, G; Navarro, D; Otero, E; Peña, JM; Soriano, V; Treviño, A | 1 |
| Bräu, N; Dieterich, DT; Miller, TR; Rivera-Mindt, M; Stivala, A; Weiss, JJ | 1 |
| Barros, C; Bellón, JM; Berenguer, J; Carrero, A; Crespo, M; Esteban, H; Galindo, MJ; Gaspar, G; González-García, J; Guardiola, JM; Jusdado, JJ; Mallolas, J; Montero, M; Montes, ML; Ortega, E; Pulido, F; Quereda, C; Rodríguez-Castellano, E; Rubio, R; Santos, I; Sanz, J; Téllez, MJ; Tural, C; Von Wichmann, MA | 1 |
| Chatelut, E; Dubois, M; Izopet, J; Lafont, T; Legrand-Abravanel, F; Nicot, F; Pasquier, C; Sauné, K | 1 |
| Lu, Y; Robinson, M; Zhang, FJ | 1 |
| Piroth, L | 1 |
| Berenguer, J; Girón, JA; González-Serrano, M; Iribarren, JA; Japón, MA; López-Cortés, LF; Macías, J; Mira, JA; Miralles, P; Moreno, A; Ortega, E; Pineda, JA; Rivero, A | 1 |
| Aghemo, A; Colombo, M; Coppola, A; Mancuso, ME; Mannucci, PM; Puoti, M; Rumi, MG; Santagostino, E | 1 |
| Nilsson, J; Weiland, O | 1 |
| Aguirrebengoa, K; Barreiro, P; Guardiola, JM; Labarga, P; Miralles, C; Miralles, P; Morello, J; Portu, J; Rodriguez-Novoa, S; Rubio, R; Soriano, V; Vispo, E | 1 |
| Beinhardt, S; Ferenci, P; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rutter, K; Staettermayer, AF | 1 |
| Barreiro, P; González-Lahoz, J; Labarga, P; Martín-Carbonero, L; Medrano, J; Soriano, V; Tuma, P; Vispo, E | 1 |
| Kovacs, A; Operskalski, EA | 1 |
| Alvarez, NP; Clotet, B; González, J; Laguno, M; Moltó, J; Ornelas, A; Paredes, R; Sánchez, M; Solà, R; Téllez, MJ; Tural, C; von Wichmann, MÁ; Zamora, AM | 1 |
| Bruno, R; Fagiuoli, S; Sacchi, P | 1 |
| Kohli, A; Kottilil, S; Masur, H; Migueles, S; Naggie, S; Polis, MA; Shivakumar, B; Sidique, N; Subramanian, GM | 1 |
| Bergin, C; Hennessy, M; Hopkins, S; Kennedy, A; Mulcahy, F; Spiers, JP | 1 |
| Di Martino, V; Kantelip, JP; Monnet, E; Montange, D; Muret, P; Piedoux, S; Piroth, L; Royer, B; Thevenot, T | 1 |
| Jablonowska, E; Nocun, M; Wojcik, K | 1 |
| Applegate, T; Dore, GJ; Feld, JJ; George, J; Grebely, J; Hellard, M; Kaldor, JM; Lloyd, AR; Matthews, GV; Petoumenos, K; Rawlinson, W; Yeung, B | 1 |
| Barreiro, P; Benito, JM; Labarga, P; Rallon, NI; Soriano, V; Vispo, E | 1 |
| Jabłonowska, E; Koślińska-Berkan, E; Omulecka, A; Piekarska, A; Szymańska, B; Wójcik, K | 1 |
| Aichelburg, MC; Breitenecker, F; Ferlitsch, A; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Schmied, B; Sieghart, W; Trauner, M | 1 |
| Camacho, A; Caruz, A; Gutierrez-Valencia, A; Lopez-Cortes, LF; Marquez-Solero, M; Pineda, JA; Rivero, A; Rivero-Juárez, A; Ruiz-Valderas, R; Torre-Cisneros, J; Torres-Cornejo, A | 1 |
| Benguria, A; Benito, JM; Fiorante, S; Garcia, MI; Lopez-Fernandez, LA; Rallon, NI; Soriano, V | 1 |
| Aichelburg, MC; Breitenecker, F; Ferlitsch, A; Mandorfer, M; Obermayer-Pietsch, B; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rieger, A; Trauner, M | 1 |
| Allen, S; Jacobs, G; Mitty, J; Schwartzapfel, B; Taylor, LE | 1 |
| Bioulac-Sage, P; Chêne, G; Dupon, M; Lacoste, D; Lafon, ME; Le Bail, B; Neau, D; Ragnaud, JM; Rullier, A; Trimoulet, P; Winnock, M | 1 |
| Anderson, JP; Daifuku, R; Loeb, LA | 1 |
| Au, WY; Lam, CC; Liu, CL; Yuen, MF | 1 |
| Thomas, DL | 1 |
| Antela, A; Bárcena, R; Diz, S; García-Garzón, S; Mateos, ML; Moreno, A; Moreno, L; Moreno, S; Muriel, A; Pérez-Elías, MJ; Quereda, C; Zamora, J | 1 |
| Fernández-Carbia, A; González-Lassalle, E; Marxuach-Cuétara, AM; Ríos-Bedoya, CF; Rodríguez-Orengo, JF; Rodríguez-Torres, M; Salgado-Mercado, R | 1 |
| Backus, LI; Boothroyd, DB; Mole, LA; Phillips, BR | 1 |
| Sherman, KE | 1 |
| Andreu, AL; Buti, M; Crespo, M; Esteban, JI; Esteban, R; Falco, V; Guardia, J; Juarez, A; Ocaña, I; Pahissa, A; Quer, J; Ribera, E; Ruiz, I; Sauleda, S | 1 |
| Dahari, H; Haller, I; Licholai, T; Markatou, M; Perelson, AS; Ribeiro, RM; Talal, AH; Zeremski, M | 1 |
| Bani-Sadr, F; Cacoub, P; Carrat, F; Denoeud, L; Lunel-Fabiani, F; Morand, P; Perronne, C; Pol, S | 1 |
| Arazo, P; Barreiro, P; Berdún, MA; Echevarría, S; Garcia-Samaniego, J; Guardiola, JM; Labarga, P; Losada, E; Miralles, C; Núñez, M; Ocampo, A; Ramos, B; Rendón, A; Romero, M; Santos, I; Soriano, V | 1 |
| Benhamou, Y; Sulkowski, MS | 1 |
| Bouajram, R; Dorn, A; Kim, AI; Saab, S | 1 |
| Aguirrebengoa, K; Arazo, P; Asensi, V; Barreiro, P; Berdún, MA; Cervantes, M; de Los Santos, I; Echeverría, S; Galindo, MJ; García-Samaniego, J; Guardiola, JM; Hernandez-Burruezo, JJ; Losada, E; Miralles, C; Núñez, M; Ocampo, A; Romero, M; San Joaquín, I; Sola, J; Soriano, V | 1 |
| Alagna, L; De Bona, A; Galli, L; Gallotta, G; Guzzo, A; Lazzarin, A; Uberti-Foppa, C | 1 |
| Carrillo-Gómez, R; Collado, A; García-García, JA; Gil, Ide L; Girón-González, JA; Gómez-Mateos, J; González-Serrano, M; López-Cortés, LF; Merino, D; Mira, JA; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Valera-Bestard, B | 1 |
| Basgoz, N; Bica, I; Birch, C; Davis, B; Gandhi, RT; Graeme-Cook, F; McGovern, BH; Quirk, JR; Stone, D; Zachary, K; Zaman, MT | 1 |
| Afdhal, NH; Brinkley, SC; de Oca, RM; Higgins, Y; Mehta, SH; Moore, RD; Sulkowski, MS; Thomas, DL; Torbenson, MS | 1 |
| Alcocer, F; Bonet, L; Cordero, M; García-Samaniego, J; López-Serrano, P; Mariño, A; Martin-Carbonero, L; Nuñez, M; Portu, J; Soriano, V | 1 |
| Abbate, I; Capobianchi, MR; D'Offizi, G; Dianzani, F; Martini, F; Narciso, P; Rozera, G | 1 |
| Blanc, D; Carrieri, MP; Dellamonica, P; Marcellin, F; Préau, M; Ravaux, I; Spire, B | 1 |
| Clotet, B; Clumeck, N; Cooper, DA; Depamphilis, J; Dieterich, DT; Montaner, J; Opravil, M; Rockstroh, JK; Sasadeusz, J; Torriani, FJ | 1 |
| Dellamonica, P; Freedberg, KA; Gastaut, JA; Marimoutou, C; Poizot-Martin, I; Pradier, C; Rosenthal, E; Tran, A; Valerio, L; Yazdanpanah, Y | 1 |
| Crespo, M; Curran, A; Esteban, JI; Falcó, V; Feijoo, M; Lopez, R; Ocaña, I; Pahissa, A; Pou, L; Ribera, E; Sauleda, S; Villar del Saz, S | 1 |
| Arizcorreta-Yarza, A; Collado, A; Fernández-Fuertes, E; Girón-González, JA; González-Serrano, M; López-Cortés, LF; Lozano, F; Macías, J; Merino, D; Mira, JA; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Torres-Tortoso, M; Valera-Bestard, B | 1 |
| Bergamaschi, V; Borghi, F; Carosi, G; Cologni, G; Gatti, F; Matti, A; Nasta, P; Puoti, M; Ricci, A | 1 |
| Karlström, O; Sönnerborg, A; Weiland, O | 1 |
| Ahluwalia, GS; Cooney, DA; Driscoll, JS; Johns, DG; Mitsuya, H; Shirasaka, T | 1 |
| Dieterich, DT; Purow, JM; Rajapaksa, R | 1 |
| Averett, DR; Bard, J; Lim, C; Pai, B; Ramasamy, K; Tam, RC | 1 |
| Lam, NP; Layden, TJ; Wiley, TE | 1 |
| Ahluwalia, GS; Broder, S; Cooney, DA; Fridland, A; Hartman, NR; Johns, DG; Kageyama, S; Mitsuya, H | 1 |
| Heseltine, PN; Hollinger, FB; Johnson, KM; Laurence, J; Lubina, JA; Makuch, RW; Parks, WP; Rasheed, S; Roberts, RB | 1 |
| Courtless, J; LeLacheur, S; Meyer, WA; Parenti, DM; Paxton, H; Schlesselman, SB; Schulof, RS; Simon, GL; Sztein, MB | 1 |
| Balzarini, J; De Clercq, E; Naesens, L; Robins, MJ | 1 |
| Hirsch, MS; Schooley, RT; Vogt, M | 1 |
| Chou, TC; Coleman, LA; Crumpacker, C; Furman, PA; Fyfe, JA; Hartshorn, KL; Hirsch, MS; Schooley, RT; Vogt, MW | 1 |
| Hirsch, MS; Kaplan, JC | 2 |
| Connor, JD; Kim, YT; Laskin, OL; Laurence, J; Murray, HW; Roberts, RB; Scavuzzo, D | 1 |
| Frank, KB; McKernan, PA; Smee, DF; Smith, RA | 1 |
| Henin, Y; Marechal, V; Montagnier, L; Schwartz, O | 1 |
| Mitchell, WM; Montefiori, DC; Robinson, WE | 1 |
| Jacobs, JL | 1 |
| Agrawal, KC; Beckman, BS; Gogu, SR | 1 |
| Broder, S; Yarchoan, R | 1 |
| Baba, M; Balzarini, J; De Clercq, E; Desmyter, J; Herdewijn, P; Pauwels, R | 1 |
| Bubley, G; Crumpacker, C; Finberg, R; Heagy, W; Hussey, S; Lee, TH; Lucey, D; McLane, MF; Monroe, JE; Schnipper, L | 1 |
Reviews
11 review(s) available for ribavirin and HIV
| Article | Year |
|---|---|
HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies.
Topics: Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Prevalence; Randomized Controlled Trials as Topic; Ribavirin | 2011 |
Viral error catastrophe by mutagenic nucleosides.
Topics: Antiviral Agents; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Models, Genetic; Mutagenesis; Nucleosides; Ribavirin; RNA Viruses | 2004 |
Options for treatment of hepatitis C in HIV-infected persons.
Topics: Antiviral Agents; Drug Carriers; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2006 |
New paradigms in the management of hepatitis C virus co-infections.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Substance-Related Disorders; Virus Replication | 2007 |
Therapeutic issues in HIV/HCV-coinfected patients.
Topics: Anemia; Antiviral Agents; Chemical and Drug Induced Liver Injury; Disease Progression; Drug Therapy, Combination; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Liver Cirrhosis; Liver Transplantation; Mitochondrial Diseases; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2007 |
The treatment of chronic hepatitis C in HIV-infected patients: a meta-analysis.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral | 2007 |
Activity of combination therapy with interferon alfa-2b plus ribavirin in chronic hepatitis C patients co-infected with HIV.
Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 1999 |
Hepatitis C viral dynamics.
Topics: Hepacivirus; Hepatitis B virus; Hepatitis C, Chronic; HIV; Humans; Interferons; Ribavirin | 1999 |
Immunologic developments in AIDS--1987.
Topics: Acquired Immunodeficiency Syndrome; Animals; Biological Factors; Clinical Trials as Topic; Colony-Stimulating Factors; Cytokines; Disease Models, Animal; Disease Susceptibility; Ethylenes; Genes, Viral; Haplorhini; Hematopoietic Stem Cells; HIV; HIV Antibodies; HIV Antigens; Humans; Mice; Receptors, HIV; Receptors, Virus; Recombinant Proteins; Retroviridae Infections; Ribavirin; Simian Immunodeficiency Virus; T-Lymphocytes; Viral Proteins | 1989 |
Progress in the development of antiviral therapy for HTLV-III-associated diseases.
Topics: Acquired Immunodeficiency Syndrome; Antimony; Antiviral Agents; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Ribavirin; Rifabutin; Rifamycins; Suramin; Thymidine; Tungsten; Tungsten Compounds; Zidovudine | 1987 |
Treatment of human immunodeficiency virus infections.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; HIV; Humans; Ribavirin; Thymidine; Zidovudine | 1987 |
Trials
17 trial(s) available for ribavirin and HIV
| Article | Year |
|---|---|
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; Coinfection; Drug Administration Schedule; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Patient Safety; Polyethylene Glycols; Prospective Studies; Protease Inhibitors; Recombinant Proteins; Ribavirin; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load | 2015 |
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.
Topics: Adult; Female; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferons; Liver Diseases; Male; Polyethylene Glycols; Ribavirin; Treatment Outcome | 2009 |
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis C.
Topics: Adult; Anemia, Hemolytic; Antiviral Agents; Epoetin Alfa; Erythrocytes; Erythropoietin; Female; Hematinics; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2010 |
Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
Topics: Adult; Antiviral Agents; Coinfection; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2011 |
Differences in HCV viral decline between low and standard-dose pegylated-interferon-alpha-2a with ribavirin in HIV/HCV genotype 3 patients.
Topics: Adult; Antiviral Agents; Coinfection; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2012 |
Comparison of 2 regimens that include interferon-alpha-2a plus ribavirin for treatment of chronic hepatitis C in human immunodeficiency virus-coinfected patients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; RNA, Viral | 2003 |
Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy.
Topics: Acute Disease; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2007 |
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients.
Topics: Adolescent; Adult; Antiviral Agents; Cell Nucleus; DNA; DNA, Mitochondrial; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin | 2007 |
Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2007 |
Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Endpoint Determination; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Spain; Species Specificity; Treatment Outcome | 2007 |
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2007 |
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Placebos; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load | 2008 |
A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group.
Topics: Administration, Oral; Adolescent; Adult; AIDS-Related Complex; Double-Blind Method; Female; Gene Products, gag; HIV; HIV Antigens; HIV Core Protein p24; HIV Infections; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ribavirin; Ribonucleosides; RNA-Directed DNA Polymerase; United States; Viral Core Proteins | 1990 |
Clinical, virologic, and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men.
Topics: Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; HIV; HIV Infections; Humans; Inosine; Inosine Pranobex; Killer Cells, Natural; Leukocyte Count; Male; Ribavirin; Ribonucleosides; T-Lymphocytes, Regulatory | 1990 |
[Chemotherapy and immunoprophylaxis of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Clinical Trials as Topic; Foscarnet; HIV; Humans; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Ribavirin; Suramin; Thymidine; Viral Vaccines; Virus Replication; Zidovudine | 1986 |
Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Clinical Trials as Topic; Double-Blind Method; HIV; Humans; Interferon-gamma; Leukocyte Count; Lymphocytes; Male; Middle Aged; Random Allocation; Reverse Transcriptase Inhibitors; Ribavirin; Ribonucleosides; Time Factors; Viral Plaque Assay; Virus Replication | 1987 |
Immunologic developments in AIDS--1987.
Topics: Acquired Immunodeficiency Syndrome; Animals; Biological Factors; Clinical Trials as Topic; Colony-Stimulating Factors; Cytokines; Disease Models, Animal; Disease Susceptibility; Ethylenes; Genes, Viral; Haplorhini; Hematopoietic Stem Cells; HIV; HIV Antibodies; HIV Antigens; Humans; Mice; Receptors, HIV; Receptors, Virus; Recombinant Proteins; Retroviridae Infections; Ribavirin; Simian Immunodeficiency Virus; T-Lymphocytes; Viral Proteins | 1989 |
Other Studies
72 other study(ies) available for ribavirin and HIV
| Article | Year |
|---|---|
Antiviral and antitumor structure-activity relationship studies on tetracyclic eudistomines.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Carbolines; HIV; Humans; Leukemia L1210; Leukemia P388; Mice; Molecular Structure; Simplexvirus; Structure-Activity Relationship; T-Lymphocytes; Tumor Cells, Cultured; Urochordata | 1992 |
Synthesis and antiviral activity of 3'-C-cyano-3'-deoxynucleosides.
Topics: Antiviral Agents; Chemical Phenomena; Chemistry; HIV; Microbial Sensitivity Tests; Moloney murine sarcoma virus; Nucleosides | 1989 |
"Viologen" dendrimers as antiviral agents: the effect of charge number and distance.
Topics: Anti-HIV Agents; Antiviral Agents; Cell Line; Dendrimers; HIV; Humans; Static Electricity; Structure-Activity Relationship; Viologens | 2010 |
New prodrugs of Adefovir and Cidofovir.
Topics: Adenine; Animals; Antiviral Agents; Cell Line, Tumor; Cidofovir; Cytomegalovirus; Cytosine; Herpesvirus 3, Human; HIV; Humans; Organophosphonates; Prodrugs; Simplexvirus | 2011 |
Design, synthesis and antiviral activity of novel quinazolinones.
Topics: Antiviral Agents; Chemistry Techniques, Synthetic; Drug Design; HIV; Quinazolinones; Tobacco Mosaic Virus | 2012 |
Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.
Topics: Antiviral Agents; Azepines; DEAD-box RNA Helicases; Dose-Response Relationship, Drug; Hepacivirus; HIV; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2014 |
Effects of Hepatitis C Virus (HCV) Eradication on Bone Mineral Density in Human Immunodeficiency Virus/HCV-Coinfected Patients.
Topics: Antiviral Agents; Bone Density; Coinfection; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2021 |
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus.
Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine | 2021 |
Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected Patients.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Immune Tolerance; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; T-Lymphocytes, Regulatory; Viral Load | 2021 |
Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C.
Topics: Adaptive Immunity; Adult; Antiviral Agents; CD4-Positive T-Lymphocytes; Coinfection; Female; Gene Expression Regulation; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Immunity, Innate; Interferon-alpha; Interferons; Interleukins; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome | 2017 |
Efficacy and safety of direct antiviral agents in a cohort of cirrhotic HCV/HIV-coinfected patients.
Topics: Antiviral Agents; Benzimidazoles; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Ribavirin; RNA, Viral; Simeprevir; Sofosbuvir; Spain; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate | 2017 |
Synthesis of a Novel Class of 1,3-oxathiolane Nucleoside Derivatives of T- 705 and Evaluation of Their Anti-influenza A Virus and Anti-HIV Activity.
Topics: Amides; Animals; Anti-HIV Agents; Dogs; HEK293 Cells; HIV; Humans; Influenza A Virus, H1N1 Subtype; Isomerism; Madin Darby Canine Kidney Cells; Nucleosides; Pyrazines; Ribavirin; Thiophenes | 2018 |
The Proof Is in the Patient: Hepatitis C Virus Microelimination in the Swiss Human Immunodeficiency Virus Cohort Study.
Topics: Amides; Benzofurans; Carbamates; Cohort Studies; Coinfection; Cyclopropanes; Hepacivirus; HIV; HIV Infections; Homosexuality, Male; Humans; Imidazoles; Male; Quinoxalines; Ribavirin; Sexual and Gender Minorities; Sulfonamides | 2019 |
Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-HIV Agents; Antiviral Agents; Cardiovascular Diseases; Coinfection; Comorbidity; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Practice Guidelines as Topic; Ribavirin; Young Adult | 2013 |
In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.
Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Logistic Models; Male; Middle Aged; Retrospective Studies; Ribavirin; Ritonavir; RNA, Viral; Viral Load; Vitamin D | 2013 |
Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo.
Topics: HIV; Interferon-alpha; Ribavirin; Virus Replication | 2014 |
Impaired HCV clearance in HIV/HCV coinfected subjects treated with PegIFN and RBV due to interference of IFN signaling by IFNαR2a.
Topics: Animals; Coinfection; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptor, Interferon alpha-beta; Ribavirin; Signal Transduction | 2014 |
Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Liver Diseases; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Polymerase Chain Reaction; Prognosis; Prospective Studies; Recombinant Proteins; Ribavirin; Survival Rate; Transplant Recipients; Treatment Outcome; Young Adult | 2014 |
Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: a prospective cohort study.
Topics: Adult; Antiviral Agents; Coinfection; Drug Carriers; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Liver Transplantation; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2015 |
Boceprevir or Telaprevir Based Triple Therapy against Chronic Hepatitis C in HIV Coinfection: Real-Life Safety and Efficacy.
Topics: Adult; Coinfection; Drug-Related Side Effects and Adverse Reactions; Europe; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Male; Middle Aged; Oligopeptides; Proline; Ribavirin; Treatment Outcome | 2015 |
Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.
Topics: 5' Untranslated Regions; Adult; Antiviral Agents; Base Sequence; Coinfection; Female; Genetic Variation; Hepacivirus; HIV; Humans; Interferon-alpha; Interleukins; Male; Middle Aged; Molecular Sequence Data; Polymorphism, Single-Stranded Conformational; Ribavirin; Sequence Alignment; Treatment Outcome; Young Adult | 2015 |
Successful Re-treatment of Hepatitis C Virus in Patients Coinfected With HIV Who Relapsed After 12 Weeks of Ledipasvir/Sofosbuvir.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Drug Therapy, Combination; Fluorenes; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Middle Aged; Recurrence; Ribavirin; Salvage Therapy; Sofosbuvir; Treatment Failure | 2016 |
Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials.
Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Prognosis; Recurrence; Ribavirin; Risk Factors; RNA, Viral; Sofosbuvir; Treatment Failure; Uridine Monophosphate | 2017 |
Greater decline in memory and global neurocognitive function in HIV/hepatitis C co-infected than in hepatitis C mono-infected patients treated with pegylated interferon and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Cognitive Dysfunction; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Neuropsychological Tests; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin | 2017 |
Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Cohort Studies; Coinfection; Comorbidity; Databases, Factual; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; HIV; Humans; Incidence; Interferon-alpha; Male; Middle Aged; Regression Analysis; Retrospective Studies; Ribavirin; Risk Assessment; Spain; Survival Analysis; Time Factors; Treatment Outcome | 2017 |
Serum concentrations of ribavirin and pegylated interferon and viral responses in patients infected with HIV and HCV.
Topics: Adult; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; ROC Curve; Serum; Treatment Outcome | 2008 |
Human immunodeficiency virus and hepatitis C virus co-infection: epidemiology, natural history and the situation in China.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; China; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
[HIV-HCV co-infection: where are we now?].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Clinical Trials as Topic; Comorbidity; France; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Interferons; Prevalence; Prognosis; Recombinant Proteins; Ribavirin; Risk Factors; Treatment Outcome | 2009 |
Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Biopsy; Cohort Studies; Disease Progression; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors | 2009 |
Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
Topics: Adult; Aged; Antiviral Agents; Chi-Square Distribution; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Predictive Value of Tests; Ribavirin; RNA, Viral; Statistics, Nonparametric; Treatment Outcome; Viral Load | 2010 |
Successful HCV eradication and inhibition of HIV replication by intravenous silibinin in an HIV-HCV coinfected patient.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Silybin; Silymarin; Treatment Outcome; Viral Load | 2010 |
Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.
Topics: Adult; Drug Combinations; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Outcome | 2011 |
Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
Topics: Antiviral Agents; Clinical Trials, Phase III as Topic; Coinfection; Drug Interactions; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferons; Oligopeptides; Proline; Ribavirin; Serine Proteases; Serine Proteinase Inhibitors; Viral Proteins | 2011 |
HIV/HCV-coinfected natural viral suppressors have better virologic responses to PEG-IFN and ribavirin than ARV-treated HIV/HCV patients.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Treatment Outcome; Virus Replication | 2011 |
Ribavirin and interferon alter MMP-9 abundance in vitro and in HIV-HCV-coinfected patients.
Topics: Adult; Antiviral Agents; Cell Line; Cohort Studies; Coinfection; Female; Hepacivirus; Hepatic Stellate Cells; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Ireland; Lopinavir; Male; Monocytes; Recombinant Proteins; Ribavirin; RNA, Viral; Saquinavir; Tissue Inhibitor of Metalloproteinase-2; United Kingdom; Viral Load | 2011 |
Relative impact of ribavirin monitoring and HIV coinfection on sustained virological response in patients with chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Cohort Studies; Coinfection; Drug Monitoring; Drug Therapy, Combination; Female; France; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Virus Replication | 2011 |
The influence of treatment with pegylated interferon-alfa and ribavirin on neutrophil function and death in patients with HIV/HCV coinfection.
Topics: Adult; Anti-HIV Agents; Antigens, CD; Antiviral Agents; Apoptosis; CD4 Lymphocyte Count; Coinfection; Female; Flow Cytometry; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Neutrophil Activation; Neutrophils; Reactive Oxygen Species; Ribavirin; Viral Load | 2012 |
Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection.
Topics: Adult; Antiviral Agents; Australia; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Seropositivity; Humans; Interferon-alpha; Interferons; Interleukins; Logistic Models; Male; Polymorphism, Single Nucleotide; Prospective Studies; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2012 |
Different impact of IL28B polymorphisms on response to peginterferon-α plus ribavirin in HIV-positive patients infected with HCV subtypes 1a or 1b.
Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Genetic; Recombinant Proteins; Ribavirin | 2012 |
Sustained virologic response and IL28B single-nucleotide polymorphisms in patients with chronic hepatitis C treated with pegylated interferon alfa and ribavirin.
Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Genotype; Genotyping Techniques; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load; Young Adult | 2012 |
A prospective evaluation of pulmonary, systemic and hepatic haemodynamics in HIV-HCV-coinfected patients before and after antiviral therapy with pegylated interferon and ribavirin.
Topics: Adult; Anti-Retroviral Agents; Cardiac Output; CD4 Lymphocyte Count; Coinfection; Familial Primary Pulmonary Hypertension; Female; Hemodynamics; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Hypertension, Portal; Hypertension, Pulmonary; Interferon-alpha; Liver; Liver Cirrhosis; Lung; Male; Middle Aged; Polyethylene Glycols; Prevalence; Prospective Studies; Ribavirin; Risk Factors; RNA, Viral; Severity of Illness Index; Treatment Outcome; Viremia | 2012 |
Interferon-stimulated genes are associated with peginterferon/ribavirin treatment response regardless of IL28B alleles in hepatitis C virus/HIV-coinfected patients.
Topics: Adult; Alleles; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Female; Gene Expression Regulation; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Spain; Treatment Outcome; Viral Load | 2013 |
Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Risk Factors; Vitamin D; Vitamin D Deficiency | 2013 |
Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence.
Topics: Anti-HIV Agents; Antiviral Agents; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Mental Disorders; Ribavirin; Substance-Related Disorders; Treatment Refusal; Viral Load | 2003 |
Hepatitis C virus infection in adult Chinese hemophilia patients negative for the human immunodeficiency virus: treatment results with interferon and ribavirin.
Topics: Adult; Aged; Antiviral Agents; China; Female; Hemophilia A; Hepatitis C; HIV; HIV Seropositivity; Humans; Interferon-alpha; Male; Middle Aged; Ribavirin; Treatment Outcome | 2005 |
Viral kinetics and early prediction of nonresponse to peg-IFN-alpha-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus.
Topics: Adult; Antiviral Agents; Female; Genotype; Hepacivirus; Hepatitis C; HIV; HIV Seropositivity; Humans; Interferon alpha-2; Interferon-alpha; Longitudinal Studies; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; RNA, Viral | 2006 |
Pretreatment assessment and predictors of hepatitis C virus treatment in US veterans coinfected with HIV and hepatitis C virus.
Topics: Cohort Studies; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; United States; United States Department of Veterans Affairs; Veterans | 2006 |
Early virologic failure in HIV-coinfected hepatitis C patients treated with the peginterferon-ribavirin combination: does abacavir play a role?
Topics: Anti-HIV Agents; Antiviral Agents; Bilirubin; Chi-Square Distribution; Dideoxynucleosides; Drug Interactions; Drug Therapy, Combination; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Multivariate Analysis; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; RNA, Viral; Time Factors; Treatment Failure; Viral Load | 2007 |
Rate of cirrhosis progression reduced in HIV/HCV co-infected non-responders to anti-HCV therapy.
Topics: Antiviral Agents; Biomarkers; Child; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Italy; Liver Cirrhosis; Male; Poisson Distribution; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; RNA, Viral; Treatment Failure; Treatment Outcome | 2007 |
Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Reverse Transcriptase Inhibitors; Ribavirin; RNA, Viral; Treatment Outcome | 2007 |
Managing symptomatic drug-induced liver injury in HIV-hepatitis C virus-coinfected patients: a role for interferon.
Topics: Anti-HIV Agents; Antiviral Agents; Biopsy; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Female; Hepatitis C; HIV; HIV Infections; Humans; Interferons; Liver; Liver Cirrhosis; Liver Diseases; Male; Necrosis; Ribavirin; RNA, Viral; Transaminases; Viral Load | 2007 |
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
Topics: Adult; Alanine Transaminase; Anti-Retroviral Agents; Antiviral Agents; Aspartate Aminotransferases; Biomarkers; Biopsy; Disease Progression; Female; Fibrosis; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Incidence; Interferons; Liver; Logistic Models; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Prospective Studies; Ribavirin | 2007 |
Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C.
Topics: Administration, Oral; Antiviral Agents; Biomarkers; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Endpoint Determination; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Hospitals; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Multicenter Studies as Topic; Polyethylene Glycols; Polymerase Chain Reaction; Predictive Value of Tests; Recombinant Proteins; Ribavirin; RNA, Viral; Spain; Treatment Outcome; Viral Load | 2008 |
Comment on Neumann et al. 'Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients'.
Topics: Administration, Oral; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis C; HIV; HIV Infections; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Viral Load; Virus Replication | 2008 |
Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients.
Topics: Adult; Anger; Anti-Retroviral Agents; Antiviral Agents; Anxiety Disorders; Cross-Sectional Studies; Female; France; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Medical Records; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Ribavirin; Surveys and Questionnaires; Treatment Outcome | 2008 |
Baseline CD4 cell count and outcome of pegylated interferon plus ribavirin therapy in HIV/hepatitis C virus-coinfected patients.
Topics: Adult; CD4 Lymphocyte Count; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2008 |
Early monitoring of ribavirin serum concentration is not useful to optimize hepatitis C virus treatment in HIV-coinfected patients.
Topics: Antiviral Agents; Drug Monitoring; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2007 |
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients.
Topics: Adult; Anemia; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Neutropenia; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Spain; Thrombocytopenia; Zidovudine | 2007 |
Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a.
Topics: Adult; Antiviral Agents; Blood Glucose; Drug Administration Schedule; Fasting; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Homeostasis; Humans; Insulin; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Polyethylene Glycols; Polymerase Chain Reaction; Recombinant Proteins; Ribavirin; RNA, Viral; Treatment Outcome; Viral Load | 2008 |
Similar hepatitis C virus RNA kinetics in HIV/hepatitis C virus monoinfected genotype 2 or 3 matched controls during hepatitis C virus combination therapy.
Topics: Adult; Antiviral Agents; Case-Control Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; Statistics, Nonparametric; Viral Load | 2008 |
Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
Topics: Adenosine Deaminase Inhibitors; Cell Line; Didanosine; Dideoxyadenosine; Drug Synergism; HIV; IMP Dehydrogenase; Pentostatin; Phosphorylation; Ribavirin | 1994 |
The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Chemical and Drug Induced Liver Injury; Concanavalin A; Cytokines; Female; Hepatitis Viruses; HIV; Humans; Male; Mice; Mice, Inbred BALB C; Rats; Ribavirin; Stereoisomerism; T-Lymphocytes | 2000 |
Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Topics: Antiviral Agents; Cells, Cultured; Chromatography; Didanosine; Dideoxyadenosine; Drug Synergism; HIV; Humans; IMP Dehydrogenase; Inosine; Inosine Monophosphate; Nucleotides; Phosphorylation; Ribavirin; Stimulation, Chemical | 1991 |
Potentiating effect of ribavirin on the in vitro and in vivo antiretrovirus activities of 2',3'-dideoxyinosine and 2',3'-dideoxy-2,6-diaminopurine riboside.
Topics: Animals; Antiviral Agents; Cell Line; Cell Transformation, Viral; Cytopathogenic Effect, Viral; Didanosine; Dideoxyadenosine; Drug Synergism; Fibroblasts; HIV; Humans; Mice; Mice, Inbred Strains; Moloney murine sarcoma virus; Ribavirin; Sarcoma, Experimental; Virus Replication | 1990 |
Ribavirin antagonizes the effect of azidothymidine on HIV replication.
Topics: Cell Line; HIV; Humans; Lymphocytes; Monocytes; Phosphorylation; Phytohemagglutinins; Ribavirin; Ribonucleosides; RNA-Directed DNA Polymerase; Thymidine; Virus Replication; Zidovudine | 1987 |
Antiviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus; DNA, Viral; Drug Resistance, Microbial; Herpesvirus 3, Human; Herpesvirus 4, Human; HIV; Humans; Interferons; Nucleosides; Reverse Transcriptase Inhibitors; Ribavirin; RNA, Messenger; RNA, Viral; Simplexvirus; Thymidine; Virus Diseases; Virus Physiological Phenomena; Virus Replication; Zidovudine | 1987 |
Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides.
Topics: Antimetabolites; Antiviral Agents; Deoxyribonucleosides; Deoxyribonucleotides; Foscarnet; HIV; Organophosphorus Compounds; Phosphonoacetic Acid; Reverse Transcriptase Inhibitors; Ribavirin; Ribonucleosides; Virus Replication; Visna-maedi virus | 1987 |
A rapid and simple colorimetric test for the study of anti-HIV agents.
Topics: Antiviral Agents; Cell Line; Colorimetry; Cytopathogenic Effect, Viral; Formazans; HIV; Humans; Microbial Sensitivity Tests; Ribavirin; RNA-Directed DNA Polymerase; Tetrazolium Salts; Thiazoles; Virus Replication; Zidovudine | 1988 |
In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Alkaloids; Amphotericin B; Antiviral Agents; Drug Therapy, Combination; Foscarnet; HIV; Humans; In Vitro Techniques; Indolizines; Interferon beta-1a; Interferon beta-1b; Interferon Type I; Interferon-beta; Interferon-gamma; Interferons; Microbial Sensitivity Tests; Phosphonoacetic Acid; Recombinant Proteins; Ribavirin; RNA, Double-Stranded; Zidovudine | 1989 |
Anti-HIV drugs: comparative toxicities in murine fetal liver and bone marrow erythroid progenitor cells.
Topics: Animals; Antiviral Agents; Bone Marrow Cells; Cells, Cultured; Colony-Forming Units Assay; Dideoxynucleosides; Fetus; Hematopoietic Stem Cells; HIV; Liver; Mice; Ribavirin; Zalcitabine; Zidovudine | 1989 |
Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro.
Topics: Cytopathogenic Effect, Viral; HIV; Purine Nucleosides; Pyrimidine Nucleosides; Ribavirin; Ribonucleosides; Virus Replication | 1987 |
Ribavirin treatment of the acquired immunodeficiency syndrome (AIDS) and the acquired-immunodeficiency-syndrome-related complex (ARC). A phase 1 study shows transient clinical improvement associated with suppression of the human immunodeficiency virus and
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Drug Evaluation; Hematocrit; HIV; Humans; Lymphocyte Activation; Male; Opportunistic Infections; Ribavirin; Ribonucleosides | 1987 |